AI brief of an SEC Form 8-K · Danaher (DHR)

Danaher names Julie Sawyer Montgomery CEO, succeeding Rainer Blair on October 1

Neutral Impact 4 of 5 leadership Written later

Danaher's board appointed Julie Sawyer Montgomery, currently Executive Vice President and head of the Diagnostics platform, as President and Chief Executive Officer effective October 1, 2026, and she joins the board at that time. Rainer Blair steps down as CEO and director and will serve as a senior advisor during the transition. The company said its third-quarter and full-year 2026 guidance is unchanged.

Key points

  • Sawyer Montgomery's base salary as CEO is $1.5 million, with a target annual cash incentive of 200% of base salary.
  • She will receive a special stock option award with a target value of $20 million, vesting 50% on the fourth and 50% on the fifth anniversary of the August 4, 2026 grant date.
  • Blair will remain a senior advisor through December 31, 2026, then serve as a consultant until March 31, 2027, and is entitled to severance including 12 months of base salary.
  • Danaher said there is no change to its previously communicated third-quarter and full-year 2026 guidance.

The filing

CompanyDanaher (DHR)
Form8-K, current report
Filed with the SECAug 3, 2026, 4:27 PM ET
Accession number0001193125-26-330652

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:16 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.